Bloomberg Intelligence cover image

BI Weekend: Novo Pill, Retail Earnings, Restaurant Sales

Bloomberg Intelligence

00:00

Novo Nordisk's Alzheimer Pill Trial Failure

Sam Fazeli explains semaglutide pill trials failed to slow Alzheimer's and debate over pill versus injection testing.

Play episode from 01:34
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app